The economic pressures for biosimilar drug use in cancer medicine

por Cornes, Paul
Publicado 2012

Biosimilar Pegfilgrastim: Improving Access and Optimising Practice to Supportive Care that Enables Cure

por Cornes, Paul, Gascon, Pere, Vulto, Arnold G., Aapro, Matti
Publicado 2020

Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia

por Cornes, Paul, Gascon, Pere, Chan, Stephen, Hameed, Khalid, Mitchell, Catherine R., Field, Polly, Latymer, Mark, Arantes, Luiz H.
Publicado 2018

Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia

por Cornes, Paul, Gascon, Pere, Chan, Stephen, Hameed, Khalid, Mitchell, Catherine R., Field, Polly, Latymer, Mark, Arantes, Luiz H.
Publicado 2018

Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer

por Aapro, Matti S., Chaplin, Stephen, Cornes, Paul, Howe, Sebastian, Link, Hartmut, Koptelova, Natalia, Mehl, Andrea, Di Palma, Mario, Schroader, Bridgette Kanz, Terkola, Robert
Publicado 2023

The changing landscape of biosimilars in rheumatology

por Dörner, Thomas, Strand, Vibeke, Cornes, Paul, Gonçalves, João, Gulácsi, László, Kay, Jonathan, Kvien, Tore K, Smolen, Josef, Tanaka, Yoshiya, Burmester, Gerd R
Publicado 2016